Skip to main content

Table 1 Comparison of clinical characteristics between localized pneumonic-type lung adenocarcinoma and pulmonary inflammatory lesion

From: Differential diagnosis of localized pneumonic-type lung adenocarcinoma and pulmonary inflammatory lesion

Characteristics

Patients with L-PLADC (n = 120)

Patients with L-PIL (n = 125)

p value

Age

  

< 0.001a

 < 58 years

35 (29.17%)

67 (53.60%)

 

 ≥ 58 years

85 (70.83%)

58 (46.40%)

 

Gender

  

< 0.001a

 Male

36 (30.00%)

89 (71.20%)

 

 Female

84 (70.00%)

36 (28.80%)

 

Smoking history

  

< 0.001a

 Nonsmokers

91 (75.83%)

55 (44.00%)

 

 Smokers

29 (24.17%)

70 (56.00%)

 

Respiratory symptoms

  

< 0.001a

 With symptoms

63 (52.50%)

101 (80.80%)

 

  Fever

6

15

 

  Cough

48

82

 

  Sputum

36

68

 

  Blood in sputum

12

28

 

  Hemoptysis

8

24

 

  Chest pain

14

25

 

 Without symptoms

57 (47.50%)

24 (19.20%)

 

Elevation of white blood cell count

13 (10.83%)

23 (18.40%)

0.094a

  1. L-PLADC—localized pneumonic-type lung adenocarcinoma, L-PIL—localized pulmonary inflammatory lesion
  2. aChi-squared test